Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 538-546

  Lubman, Olga Y ^a   Cella, Marina ^a   Wang, Xinxin ^a   Monte, Kristen ^a   Lenschow, Deborah J ^a   Huang, Yina H ^a,b   Fremont, Daved H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; DECOY RECEPTOR 3; EOTAXIN 2; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; GENETIC CODE; HERPES VIRUS; HUMAN HERPESVIRUS 8; IMMUNE EVASION; IMMUNE RESPONSE; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN SECRETION; RHADINOVIRUS;

ANIMALS; CALCIUM; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; HEK293 CELLS; HUMANS; MICE; OPEN READING FRAMES; RECEPTORS, CHEMOKINE; RHADINOVIRUS; SURFACE PLASMON RESONANCE;

EID: 84890880272     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02729-13     Document Type: Article

References (52)

1. Loh J, Zhao G, Nelson CA, Coder P, Droit L, Handley SA, Johnson LS, Vachharajani P, Guzman H, Tesh RB, Wang D, Fremont DH, Virgin HW. 2011. Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice. J. Virol. 85:2642-2656. http://dx.doi.org/10.1128/JVI.01661-10.
2. Virgin HW, IV, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ, Speck SH. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
3. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:14862-14867. http://dx.doi.org/10.1073/pnas .93.25.14862.
4. Herr RA, Wang X, Loh J, Virgin HW, Hansen TH. 2012. Newly discovered viral E3 ligase pK3 induces endoplasmic reticulum-associated degradation of class I major histocompatibility proteins and their membrane-bound chaperones. J. Biol. Chem. 287:14467-14479. http://dx.doi .org/10.1074/jbc.M111.325340.
5. Alcami A, Koszinowski UH. 2000. Viral mechanisms of immune evasion. Immunol. Today 21:447-455. http://dx.doi.org/10.1016/S0167-5699(00)01699-6.
6. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377-423. http://dx.doi.org/10 .1146/annurev.immunol.21.120601.141049.
7. Murphy PM. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116-122. http://dx .doi.org/10.1038/84214.
8. Epperson ML, Lee CA, Fremont DH. 2012. Subversion of cytokine networks by virally encoded decoy receptors. Immunol. Rev. 250:199-215. http://dx.doi.org/10.1111/imr.12009.
9. Alcami A, Lira SA. 2010. Modulation of chemokine activity by viruses. Curr. Opin. Immunol. 22:482-487. http://dx.doi.org/10.1016/j.coi.2010 .06.004.
10. Alcami A, Smith GL. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
11. Alcami A, Smith GL. 2002. The vaccinia virus soluble interferon-gamma receptor is a homodimer. J. Gen. Virol. 83:545-549.
12. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
13. Lau EK, Allen S, Hsu AR, Handel TM. 2004. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Adv. Protein Chem. 68:351-391. http://dx.doi.org/10.1016/S0065-3233(04)68010-7.
14. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH. 2002. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111: 343-356. http://dx.doi.org/10.1016/S0092-8674(02)01007-3.
15. Alexander-Brett JM, Fremont DH. 2007. Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J. Exp. Med. 204:3157-3172. http://dx.doi.org/10.1084/jem.20071677.
16. Wang D, Bresnahan W, Shenk T. 2004. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. U. S. A. 101:16642-16647. http://dx.doi.org/10.1073/pnas.0407233101.
17. Viejo-Borbolla A, Martinez-Martin N, Nel HJ, Rueda P, Martin R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcami A. 2012. Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses. PLoS Pathog. 8:e1002497. http://dx .doi.org/10.1371/journal.ppat.1002497.
18. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu LY, Lucas A, Clark-Lewis I, Moyer RW, McFadden G. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12-24. http://dx.doi.org/10 .1006/viro.1996.8423.
19. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. 1998. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:624-633.
20. Arnold PL, Fremont DH. 2006. Structural determinants of chemokine binding by an ectromelia virus-encoded decoy receptor. J. Virol. 80:7439-7449. http://dx.doi.org/10.1128/JVI.00576-06.
21. Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, Kelvin D, McFadden G. 1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71:4356-4363.
22. Bahar MW, Kenyon JC, Putz MM, Abrescia NG, Pease JE, Wise EL, Stuart DI, Smith GL, Grimes JM. 2008. Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog. 4:e5. http://dx .doi.org/10.1371/journal.ppat.0040005.
23. Ruiz-Arguello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, Alcami A. 2008. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J. Virol. 82:917-926. http://dx.doi.org/10.1128/JVI.02111-07.
24. Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, Alcami A. 2006. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl. Acad. Sci. U. S. A. 103:5995-6000. http://dx.doi.org/10.1073/pnas.0510462103.
25. Lalani AS, Masters J, Graham K, Liu L, Lucas A, McFadden G. 1999. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 256:233-245. http://dx.doi.org/10.1006/viro.1999.9617.
26. Lateef Z, Baird MA, Wise LM, Mercer AA, Fleming SB. 2009. Orf virus-encoded chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin model. J. Gen. Virol. 90: 1477-1482. http://dx.doi.org/10.1099/vir.0.009589-0.
27. Lateef Z, Baird MA, Wise LM, Young S, Mercer AA, Fleming SB. 2010. The chemokine-binding protein encoded by the poxvirus ORF virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cell. Microbiol. 12:665-676. http://dx.doi.org/10.1111/j.1462-5822.2009.01425.x.
28. van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HW, IV. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 109:905-914. http://dx.doi.org/10.1172/JCI14358.
29. Hughes DJ, Kipar A, Sample JT, Stewart JP. 2010. Pathogenesis of a model gammaherpesvirus in a natural host. J. Virol. 84:3949-3961. http://dx.doi.org/10.1128/JVI.02085-09.
30. Hughes DJ, Kipar A, Leeming GH, Bennett E, Howarth D, Cummerson JA, Papoula-Pereira R, Flanagan BF, Sample JT, Stewart JP. 2011. Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host. PLoS Pathog. 7:e1001321. http://dx.doi.org/10.1371/journal.ppat.1001321.
31. Proudfoot AE, Borlat F. 2000. Purification of recombinant chemokines from E. coli. Methods Mol. Biol. 138:75-87.
32. Miley MJ, Truscott SM, Yu YY, Gilfillan S, Fremont DH, Hansen TH, Lybarger L. 2003. Biochemical features of the MHC-related protein 1 consistent with an immunological function. J. Immunol. 170:6090-6098.
33. Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4:363-371. http://dx.doi .org/10.1038/nprot.2009.2.
34. Houser B. 2012. Bio-Rad's Bio-Plex(R) suspension array system, xMAP technology overview. Arch. Physiol. Biochem. 118:192-196. http://dx.doi .org/10.3109/13813455.2012.705301.
35. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102. http://dx.doi.org/10.1126/science.286 .5447.2098.
36. Moser B, Loetscher P. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:123-128. http://dx.doi.org/10.1038/84219.
37. Jensen KK, Chen SC, Hipkin RW, Wiekowski MT, Schwarz MA, Chou CC, Simas JP, Alcami A, Lira SA. 2003. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J. Virol. 77:624-630. http://dx .doi.org/10.1128/JVI.77.1.624-630.2003.
38. Maghazachi AA. 2000. Intracellular signaling events at the leading edge of migrating cells. Int. J. Biochem. Cell Biol. 32:931-943. http://dx.doi.org/10.1016/S1357-2725(00)00035-2.
39. van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, Mc-Fadden G, Speck SH, Virgin HI. 2000. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74:6741-6747. http://dx.doi.org/10.1128/JVI.74.15.6741-6747 .2000.
40. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100:1885-1890. http://dx.doi .org/10.1073/pnas.0334864100.
41. Esko JD, Weinke JL, Taylor WH, Ekborg G, Roden L, Anantharamaiah G, Gawish A. 1987. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J. Biol. Chem. 262:12189-12195.
42. Cardin AD, Weintraub HJ. 1989. Molecular modeling of proteinglycosaminoglycan interactions. Arteriosclerosis 9:21-32. http://dx.doi .org/10.1161/01.ATV.9.1.21.
43. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. 1998. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156-167. http://dx.doi.org/10 .1002/(SICI)1521-1878(199802)20:2 156::AID-BIES83.0.CO;2-R.
44. Lau EK, Paavola CD, Johnson Z, Gaudry JP, Geretti E, Borlat F, Kungl AJ, Proudfoot AE, Handel TM. 2004. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279:22294-22305. http://dx.doi .org/10.1074/jbc.M311224200.
45. Seet BT, Barrett J, Robichaud J, Shilton B, Singh R, McFadden G. 2001. Glycosaminoglycan binding properties of the myxoma virus CCchemokine inhibitor, M-T1. J. Biol. Chem. 276:30504-30513. http://dx .doi.org/10.1074/jbc.M011401200.
46. Lucas A, McFadden G. 2004. Secreted immunomodulatory viral proteins as novel biotherapeutics. J. Immunol. 173:4765-4774.
47. Dabbagh K, Xiao Y, Smith C, Stepick-Biek P, Kim SG, Lamm WJ, Liggitt DH, Lewis DB. 2000. Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J. Immunol. 165:3418-3422.
48. Bursill CA, Cai S, Channon KM, Greaves DR. 2003. Adenoviralmediated delivery of a viral chemokine binding protein blocks CCchemokine activity in vitro and in vivo. Immunobiology 207:187-196. http://dx.doi.org/10.1078/0171-2985-00228.
49. Liu L, Dai E, Miller L, Seet B, Lalani A, Macauley C, Li X, Virgin HW, Bunce C, Turner P, Moyer R, McFadden G, Lucas A. 2004. Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 77:1652-1660. http://dx.doi.org/10.1097/01.TP.0000131173.52424.84.
50. Rice J, de Lima B, Stevenson FK, Stevenson PG. 2002. A gammaherpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur. J. Immunol. 32: 3481-3487. http://dx.doi.org/10.1002/1521-4141(200212)32:12 3481::AID-IMMU34813.0.CO;2-J.
51. Pyo R, Jensen KK, Wiekowski MT, Manfra D, Alcami A, Taubman MB, Lira SA. 2004. Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am. J. Pathol. 164:2289-2297. http://dx.doi.org/10.1016/S0002-9440(10)63785-6.
52. Martin AP, Canasto-Chibuque C, Shang L, Rollins BJ, Lira SA. 2006. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J. Immunol. 177:7296-7302.